Novo Nordisk (NVO) has released an update.
Novo Nordisk A/S, a global healthcare leader, has announced the continuation of its 2024 share repurchase program with a new buyback plan worth up to DKK 2.2 billion. The program aims to reduce the company’s share capital and fulfill obligations from share-based incentive plans, allowing for the repurchase of up to 350 million B shares between May 7 and August 5, 2024. This move underscores Novo Nordisk’s ongoing commitment to maximize shareholder value and support its strategic financial objectives.
For further insights into NVO stock, check out TipRanks’ Stock Analysis page.
